DUSA PHARMACEUTICALS CLOSES ACQUISITION OF SIRIUS LABORATORIES

Dusa Pharmaceuticals, Inc., developer and marketer of Levulan photodynamic therapy (PDT) for the treatment of dermatologic conditions, announced today that it has closed the acquisition by merger of Sirius Laboratories Inc. of Vernon Hills, Illinois ("Sirius") into a wholly-owned subsidiary of Dusa which will be called Sirius.
Laboratories, Inc. CCNMatthews